preoper high-dos radiat therapi unresect rectal cancer patient primari recurr unresect rectal cancer pelvi phase trial preoper pelvic radiat therapi RT cgi cycl combin high-dos leucovorin LV surgeri ten cycl postop sequenti maximum toler dose mtd preoper RT postop sequenti LV constant initi dose RT sequenti median follow-up time month resect rate patholog complet respons rate mtd RT dose recommend dose sequenti dose-limit toxic trial diarrhea tenesmu bowel movement dysuria myelosuppress patient dose level median low count leukocyt count rang g/dl rang g/dl count rang incid rate grade toxic diarrhea frequent bowel movement recommend dose protocol long delay optim dose author high-dos LV conjunct combin RT treatment regimen resect complet respons rate preoper RT author techniqu approach new trial use low-dos LV regimen toler 